Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Other Accumulated Expenses (2023 - 2025)

INVO Fertility (IVF) has disclosed Other Accumulated Expenses for 3 consecutive years, with $10500.0 as the latest value for Q3 2025.

  • Quarterly Other Accumulated Expenses fell 97.0% to $10500.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $10500.0 through Sep 2025, down 97.0% year-over-year, with the annual reading at $410000.0 for FY2024, 17.14% up from the prior year.
  • Other Accumulated Expenses for Q3 2025 was $10500.0 at INVO Fertility, roughly flat from $10500.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $715245.0 in Q1 2025, with the low at $10500.0 in Q2 2025.
  • Average Other Accumulated Expenses over 3 years is $296630.8, with a median of $350000.0 recorded in 2023.
  • The sharpest move saw Other Accumulated Expenses soared 183.56% in 2024, then tumbled 97.0% in 2025.
  • Over 3 years, Other Accumulated Expenses stood at $350000.0 in 2023, then grew by 17.14% to $410000.0 in 2024, then plummeted by 97.44% to $10500.0 in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $10500.0, $10500.0, and $715245.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.